In a patient with iron deficiency anemia, ferritin 10 µg/L and hemoglobin 12.0 g/dL who experiences flatulence on ferrous sulfate 325 mg daily, what oral iron preparation should be switched to?

Switch to Alternate-Day Ferrous Sulfate or Consider Ferric Maltol

For a patient with iron deficiency (ferritin 10 µg/L, hemoglobin 12.0 g/dL) experiencing flatulence on ferrous sulfate 325 mg daily, switch to ferrous sulfate 325 mg every other day as the first-line strategy, or consider ferric maltol if alternate-day dosing remains intolerable. 1

Rationale for Alternate-Day Dosing

The British Society of Gastroenterology 2021 guidelines explicitly recommend that when oral iron is not tolerated, a reduced dose of one tablet every other day should be considered before switching formulations 1. This recommendation is based on physiological evidence showing that:

• Daily iron supplementation elevates hepcidin levels for up to 48 hours, which blocks subsequent iron absorption 1
• Alternate-day dosing significantly increases fractional iron absorption compared to daily dosing 1
• Intermittent oral iron is associated with lower incidence of GI adverse events (relative risk 0.56) while maintaining similar hemoglobin improvements after equivalent total doses 1

The 2024 AGA guidelines reinforce this, stating that every-other-day iron dosing may be better tolerated with similar or equal rates of iron absorption as daily dosing 2.

Why Not Switch Iron Salts

The standard practice of switching to a different traditional iron salt (ferrous fumarate or ferrous gluconate) is not supported by evidence 1. The 2024 AGA guidelines confirm that no single formulation of oral iron has any advantages over any other 2. All ferrous salts cause similar GI side effects because the issue is elemental iron exposure to the GI tract, not the specific salt formulation.

Alternative: Ferric Maltol

If alternate-day ferrous sulfate remains intolerable, ferric maltol is the evidence-based oral alternative 1. In patients with previous intolerance to traditional iron salts:

• Ferric maltol normalized hemoglobin in 63-66% at 12 weeks 1
• GI side effects and treatment cessation rates were comparable to placebo 1
• The main limitation is slower iron loading due to lower iron content (30 mg elemental iron per tablet) 1

When to Consider IV Iron

Parenteral iron should be considered when oral iron is contraindicated, ineffective, or not tolerated 1. The 2024 AGA guidelines specify IV iron is indicated if 2:

• Patient cannot tolerate oral iron despite dosing adjustments
• Ferritin fails to increase after one month of adherent oral therapy
• Hemoglobin fails to increase by ≥1 g/dL within 2 weeks

Practical Algorithm

1. First step: Switch to ferrous sulfate 325 mg (65 mg elemental iron) every other day

   • Take on empty stomach with 500 mg vitamin C to enhance absorption 2
   • Avoid tea/coffee within 1 hour of dosing 2

2. Monitor response at 2-4 weeks: Check hemoglobin

   • Expected increase: ≥1 g/dL by 2 weeks indicates adequate response 1, 2

3. If intolerant to alternate-day dosing: Switch to ferric maltol 30 mg twice daily

4. If no response or continued intolerance: Proceed to IV iron (ferric carboxymaltose or ferric derisomaltose preferred for single-dose administration) 2

Important Caveats

Your patient's hemoglobin of 12.0 g/dL is not severely anemic (only mildly below normal for women), so there is no urgency requiring immediate IV iron. The ferritin of 10 µg/L confirms true iron deficiency requiring repletion. Continue treatment for approximately 3 months after hemoglobin normalization to replenish iron stores 1.

The flatulence specifically may improve with alternate-day dosing since GI side effects (including bloating and flatulence) are dose-dependent and related to the amount of unabsorbed iron in the GI tract 1.